Abdel-Wahab M, Fidarova E, Polo A
Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.
Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.
Clin Oncol (R Coll Radiol). 2017 Feb;29(2):99-104. doi: 10.1016/j.clon.2016.12.004.
Over the last 60 years, the International Atomic Energy Agency (IAEA) has been working to introduce, expand and improve radiotherapy services, working with partners such as the World Health Organization (WHO) to improve cancer diagnosis, treatment, care and control through collective action in low- and middle-income countries (LMICs). The Lancet Oncology Commission on radiotherapy published a report that defined five calls for action to expand global access to radiotherapy, drawing on the previous work of the Global Taskforce on Radiotherapy for Cancer Control. The IAEA supports LMICs in the development of the required national infrastructure and regulatory authority for radiation and nuclear safety and in the training of human resources necessary for the provision of high-quality effective and safe radiation medicine services for the diagnosis, treatment and palliative care of cancer patients, helping in this way to address the different priorities outlined in the Lancet Commission report.
在过去60年里，国际原子能机构（IAEA）一直致力于引入、扩大和改善放射治疗服务，与世界卫生组织（WHO）等伙伴合作，通过在低收入和中等收入国家（LMICs）采取集体行动，改善癌症的诊断、治疗、护理和控制。《柳叶刀肿瘤学委员会关于放射治疗的报告》发表了一份报告，借鉴癌症控制放射治疗全球特别工作组以前的工作，确定了扩大全球放射治疗可及性的五项行动呼吁。IAEA支持低收入和中等收入国家发展所需的国家基础设施以及辐射与核安全监管机构，并培训提供高质量有效且安全的放射医学服务所需的人力资源，以用于癌症患者的诊断、治疗和姑息治疗，从而帮助解决《柳叶刀委员会报告》中概述的不同优先事项。
